Prevalence of HPV infection in precancerous and cancerous lesions of the uterine cervix in Tunisia;Prévalence des infections à papillomavirus (HPV) dans les lésions précancéreuses et cancéreuses du col utérin en Tunisie

Annales de Biologie Clinique

Volumn 68, Issue 3, 2010, Pages 297-303

  Missaoui, Nahiba ^a   Hmissa, Sihem ^a,b   Trabelsi, Amel ^b   Yacoubi, Mohamed Tahar ^b   Nouira, Amel ^b   Frappart, Lucien ^c   Mokni, Moncef ^b   Korbi, Sadok ^b  

^a UNIVERSITY OF SOUSSE   (Tunisia)

^b FARHAT HACHED HOSPITAL   (Tunisia)

^c EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Cancer; HPV; Precancerous lesions; Uterine cervix; Vaccine

Indexed keywords

VIRUS DNA;

ARTICLE; CARCINOMA; FEMALE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; PAPILLOMAVIRUS INFECTION; PRECANCER; PREVALENCE; RETROSPECTIVE STUDY; TUNISIA; UTERINE CERVIX TUMOR; VIROLOGY;

CARCINOMA; DNA, VIRAL; FEMALE; HUMANS; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; PREVALENCE; RETROSPECTIVE STUDIES; TUNISIA; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 77952834062     PISSN: 00033898     EISSN: 19506112     Source Type: Journal    
DOI: 10.1684/abc.2010.0431     Document Type: Article

References (34)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Bergeron C, Breugelmans JG, Bouee S, Lorans C, Benard S, Remy V. Cervical cancer screening and associated treatment costs in France. Gynecol Obstet Fertil 2006; 34: 1036-1042
3. North AB, South CD. Cancer incidence in Antarctica, 1998-2002. In: Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al., eds. Cancer incidence in five continents. Vol.IX. Lyon: IARC Scientific Publications, 2007: 160.
4. zur Hausen H. Papillomavirus infections--a major cause of human cancers. Biochim Biophys Acta 1996; 1288: 55-78.
5. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002; 2: 342-350
6. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a metaanalysis. Br J Cancer 2003; 88: 63-73.
7. Wright Jr TC, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002; 287: 2120-2129
8. Monsonego J. Évaluation de l'intérêt de la recherche des papillomavirus humains (HPV) dans le dépistage des lésions précancéreuses et cancéreuses du col de l'utérus (mai 2004). Gynecol Obstet Fertil 2005; 33: 357-360 (952-5).
9. Michels KB, zur Hausen H. HPV vaccine for all. Lancet 2009; 374: 268-270
10. Hantz S, Alain S, Denis F. Vaccins prophylactiques antipapillomavirus : enjeux et perspectives. Gynecol Obstet Fertil 2006; 34: 647-655
11. Vonka V, Hamsíková E. Vaccines against human papillomaviruses-a major breakthrough in cancer prevention. Cent Eur J Public Health 2007; 15: 131-139
12. Wells M, Ostor AG, Crum CP, Franceschi S, Tommasino M, Nesland JM, et al. Tumours of the breast end female genital organs. Lyon: IARC Press, 2003.
13. Missaoui N, Hmissa S, Frappart L, Trabelsi A, Ben Abdelkader A, Traore C, et al. p16INK4A overexpression and HPV infection in uterine cervix adenocarcinoma. Virchows Arch 2006; 448: 597-603.
14. Snijders PJ, van den Brule AJ, Schrijnemakers HF, Snow G, Meijer CJ, Walboomers JM. The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J Gen Virol 1990; 71: 173-181
15. Soler C, Allibert P, Chardonnet Y, Cros P, Mandrand B, Thivolet J. Detection of human papillomavirus types 6, 11, 16 and 18 in mucosal and cutaneous lesions by the multiplex polymerase chain reaction. J Virol Methods 1991; 35: 143-157
16. Kovacic MB, Katki HA, Kreimer AR, Sherman ME. Epidemiologic analysis of histologic cervical inflammation: relationship to human papillomavirus infections. Hum Pathol 2008; 39: 1088-1095
17. Ding DC, Hsu HC, Huang RL, Lai HC, Lin CY, Yu MH, et al. Type-specific distribution of HPV along the full spectrum of cervical carcinogenesis in Taiwan: an indication of viral oncogenic potential. Eur J Obstet Gynecol Reprod Biol 2008; 140: 245-251
18. Hong D, Ye F, Chen H, Lu W, Cheng Q, Hu Y, et al. Distribution of human papillomavirus genotypes in the patients with cervical carcinoma and its precursors in Zhejiang Province, China. Int J Gynecol Cancer 2008; 18: 104-109
19. Clifford GM, Rana RK, Franceschi S, Smith JS, Gough G, Pimenta JM. Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 1157-1164
20. Zhao Y, Lin H, Shen D, Xuan Y, Lin Z. Distribution of HPV genotypes in uterine cervical lesions in Yanbian, northern China. Pathol Int 2008; 58: 643-647
21. Pretet JL, Jacquard AC, Carcopino X, Charlot JF, Bouhour D, Kantelip B, et al. Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study. Int J Cancer 2008; 122: 428-432 (Pubitemid 350234732)
22. Bergeron C, Barrasso R, Beaudenon S, Flamant P, Croissant O, Orth G. Human papillomaviruses associated with cervical intraepithelial neoplasia. Great diversity and distinct distribution in low- and highgrade lesions. Am J Surg Pathol 1992; 16: 641-649
23. Clifford G, Franceschi S, Diaz M, Munoz N, Villa LL. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine 2006; 24: 26-34.
24. Siriaunkgul S, Suwiwat S, Settakorn J, Khunamornpong S, Tungsinmunkong K, Boonthum A, et al. HPV genotyping in cervical cancer in Northern Thailand. Adapting the linear array HPV assay for use on paraffin-embedded tissue. Gynecol Oncol 2008; 108: 555-560
25. Odida M, de Sanjosé S, Quint W, Bosch XF, Klaustermeier J, Weiderpass E. Human papillomavirus type distribution in invasive cervical cancer in Uganda. BMC Infect Dis 2008; 8: 85.
26. Hammouda D, Munoz N, Herrero R, Arslan A, Bouhadef A, Oublil M, et al. Cervical carcinoma in Algiers, Algeria: human papillomavirus and lifestyle risk factors. Int J Cancer 2005; 113: 483-489
27. Castellsague X, de Sanjose S, Aguado T, Louie KS, Bruni L, Munoz J, et al. HPV and cervical cancer in the world, 2007 Report. Vaccine 2007; 25 (Suppl. 3): C1-C230.
28. Clifford GM, Smith JS, Plummer M, Muñoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003; 88: 63-73.
29. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 2007; 121: 621-632
30. Andersson S, Rylander E, Larsson B, Strand A, Silfversvard C, Wilander E. The role of human papillomavirus in cervical adenocarcinoma carcinogenesis. Eur J Cancer 2001; 37: 246-250
31. Pirog EC, Kleter B, Olgac S, Bobkiewicz P, Lindeman J, Quint WG, et al. Prevalence of human papillomavirus DNA in different histologicalsubtypes of cervical adenocarcinoma. Am J Pathol 2000; 157: 1055-1062
32. An HJ, Kim KR, Kim IS, Kim DW, Park MH, Park IA, et al. Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma: a population-based study. Mod Pathol 2005; 18: 528-534
33. Sahasrabuddhe VV, Mwanahamuntu MH, Vermund SH, Huh WK, Lyon MD, Stringer JS, et al. Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia. Br J Cancer 2007; 96: 1480-1483
34. Onusida OMS. Report on the global AIDS epidemic 2008. Genève: Onusida, 2008.